EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Coordination of SLC39A1 and DRP1 facilitates HCC recurrence by impairing mitochondrial quality control

Rui Li, Zhe Wang, Lixin Cheng iD, Zhiqiang Cheng, Qiong Wu, Fengjuan Chen, Dong Ji, Qingxian Cai, Yijin Wang iD

Clinical and Translational Medicine · 2025

DOI: 10.1002/ctm2.70362 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Medicine, 2025. Verfasst von Rui Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Joint Laboratory of Guangdong-Hong Kong Universities for Vascular Homeostasis and Diseases, School of Medicine, Southern …. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Cation Transport Proteins, Dynamins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, International science and technology cooperation of ShenZhen, International Science and Technology Cooperation of Guangdong.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Despite rapid advances in HCC therapy, surgical resection is still the most effective treatment. However, postoperative relapse develops in a large population and the mechanism remains to be explored.

Methods

HCC resection samples were retrospectively collected from 12 nonrelapsed and 15 relapsed HCC patients for RNA sequencing. Liver‐specific solute carrier family 39 member 1 (SLC39A1) knockout mice were generated by crossing Alb‐Cre mice and SLC39A1 flox/flox mice. Liver samples were examined for inflammation, fibrosis, proliferation, and apoptosis. Mitochondrial mass, autophagy, ROS, and mitochondrial membrane potential (MMP), were detected. Co‐immunoprecipitation and molecular docking were used to identify protein interactions.

Results

SLC39A1 is highly expressed in relapsed HCC patients and negatively correlated with overall survival. Knockdown of SLC39A1 inhibited cell proliferation by arresting the cell cycle and promoted cell apoptosis, accompanied by suppressing autophagic flux. Mechanistically, SLC39A1 interacts with a member of the dynamin superfamily of GTPases dynamin‐related protein 1 (DRP1), followed by facilitating mitochondrial fission and MMP reduction. Inhibition of DRP1 abolished SLC39A1‐induced mitochondrial division and MMP depolarization, while overexpression of DRP1 reversed mitochondrial fusion and MMP hyperpolarization in SLC39A1 silenced cells, accompanied by recuperative cell proliferative ability. SLC39A1 flox/flox ,Alb‐Cre mice displayed fewer tumour numbers and less liver damage compared with SLC39A1 flox/flox mice. A specific peptide targeting SLC39A1 to disturb the combination of full‐length SLC39A1 and DRP1 efficiently suppressed HCC progression.

Conclusions

Our findings reveal a key role of SLC39A1‐DRP1 interaction in HCC progression by disturbing mitochondrial quality control and providing a competitive peptide as a potential anti‐tumour therapy. Key points SLC39A1 correlates with HCC recurrence and HCC mortality. Interaction of SLC39A1 and DRP1 facilitates HCC by regulating mitochondrial quality control. Specific peptide targeting SLC39A1 efficiently prevents HCC progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsCation Transport ProteinsDynaminsMitochondriaNeoplasm Recurrence, LocalAnimalsHumansMiceMaleFemaleMice, KnockoutRetrospective Studies

Stichwörter der Autor:innen

HCC relapsecancer therapyhepatocellular carcinomamitochondrial quality control

Substanzen

Cation Transport ProteinsDynaminsDNM1L protein, human

Autor:innen und Institutionen

  • Department of Pharmacology, Joint Laboratory of Guangdong-Hong Kong Universities for Vascular Homeostasis and Diseases, School of Medicine, Southern University of Science and Technology, Shenzhen, China.
  • SUSTech Homeostatic Medicine Institute, School of Medicine, Southern University of Science and Technology, Shenzhen, China.
  • Department of Critical Care Medicine, Shenzhen People's Hospital, the First Affiliated Hospital of Southern University of Science and Technology, the Second Clinical Medical College of Jinan University, Shenzhen, China.
  • Department of Pathology, The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen, China.
  • School of Basic Medicine, North Sichuan Medical College, Nanchong, China.
  • Department of Hepatopathy, The Eighth Affiliated Hospital of the Guangzhou Medical University, Guangzhou, China.

ORCID-Profile: Lixin Cheng, Yijin Wang

Förderung

  • National Natural Science Foundation of China
  • International science and technology cooperation of ShenZhen
  • International Science and Technology Cooperation of Guangdong
  • Shenzhen government and SUSTech for talent research start-up funding
  • Guangzhou Science and Technology Plan Project

Zitieren

APA

Li, R., Wang, Z., Cheng, L., Cheng, Z., Wu, Q., Chen, F., Ji, D., Cai, Q., & Wang, Y. (2025). Coordination of SLC39A1 and DRP1 facilitates HCC recurrence by impairing mitochondrial quality control. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.70362

Vancouver

Li R, Wang Z, Cheng L, Cheng Z, Wu Q, Chen F, et al. Coordination of SLC39A1 and DRP1 facilitates HCC recurrence by impairing mitochondrial quality control. Clinical and Translational Medicine. 2025. doi:10.1002/ctm2.70362

BibTeX
@article{Li2025,
  author = {Li, Rui and Wang, Zhe and Cheng, Lixin and Cheng, Zhiqiang and Wu, Qiong and Chen, Fengjuan and Ji, Dong and Cai, Qingxian and Wang, Yijin},
  title = {Coordination of SLC39A1 and DRP1 facilitates HCC recurrence by impairing mitochondrial quality control},
  journal = {Clinical and Translational Medicine},
  year = {2025},
  doi = {10.1002/ctm2.70362}
}
Kostenlos starten →